Virulence factors and drug resistance in Escherichia coli isolated from extraintestinal infections

Indian Journal of Medical Microbiology

Volumn 25, Issue 4, 2007, Pages 369-373

  Sharma, S ^a   Bhat, G ^a   Shenoy, S ^a  

^a KASTURBA MEDICAL COLLEGE   (India)

Author keywords

Drug resistance; Escherichia coli; Haemolysin; Serum resistance; Surface hydrophobicity

Indexed keywords

AMIKACIN; AMPICILLIN; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; HEMOLYSIN; NETILMICIN; PROTEINASE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; DISK DIFFUSION; ESCHERICHIA COLI; HUMAN; HYDROPHOBICITY; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; SCREENING; STATISTICAL SIGNIFICANCE;

EID: 37549058402     PISSN: 02550857     EISSN: 02550857     Source Type: Journal    
DOI: 10.4103/0255-0857.37341     Document Type: Article

References (22)

1. Picard B, Garcia JS, Gouriou S, Duriez P, Brahimi N, Bingen E, et al. The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect Immun 1999;67:546-53.
2. Johnson JR, Russo TA. Extraintestinal pathogenic Escherichia coli: "the other bad E coli". J Lab Clin Med 2002;139:155-62
3. Mathur P, Kapil A, Das B, Dhawan B. Prevalence of ESBL producing gram negative bacteria in a tertiary care hospital. Indian J Med Res 2002;115:153-7.
4. th ed. Collee JG, Fraser AG, Marmion BP, Siminons A, editors. (Churchill Livingston: New York) 1996. p. 361-4.
5. Siegfried L, Kmetova M, Puzova H, Molokacova M, Filka J. Virulence associated factors in Escherichia coli strains isolated from children with urinary tract infections. J Med Microbiol 1994;41:127-32.
6. Raksha R, Srinivasa H, Macaden RS. Occurrence and characterization of uropathogenic Escherichia coli in urinary tract infections. Indian J Med Microbiol 2003;21:102-7.
7. th ed. Collee JG, Fraser AG, Marmion BP, Simmon A, editors. (Churchill Livingston: New York) 1996. p. 131-49.
8. Jain A, Roy I, Gupta MK, Kumar M, Agarwal SK. Prevalence of extended spectrum β-lactamase producing gram negative bacteria in septicaemic neonates in a tertiary care hospital. J Med Microbiol 2003;52:421-5.
9. st century: Characterisation, epidemiology and detection of this important resistance threat. Clin Microbiol Rev 2001;:933-51.
10. National committee for clinical laboratory standards. Performance standards for antimicrobial disc susceptibility tests. Approved standard M2-A7. National Committee for Clinical Laboratory Standards: Wayne, PA; 2000.
11. Emody L, Kerenyi M, Nagy G. Virulence factors of uropathogenic Escherichia coli. Int J Antimicrob Agents 2003;22:29-33.
12. Jhonson JR. Virulence factor in E. coli urinary tract infection. Clin Microbiol Rev 1991;14:81-8.
13. Suman E, Gopalkrishna Bhat K, Hegde BM. Bacterial adherence and immune response in recurrent UTI. Int J Gynaecol Obstet 2001;75:263-8.
14. Hughes C, Phillips R, Roberts PA. Serum resistance among Escherichia coli strains causing urinary tract infection in relation to O type and the carriage of hemolysin, colicin, and antibiotic resistance determinants. Infect Immun 1982;35:270-5.
15. Chitnis SV, Chitris V, Sharma N, Chitnis DS. Current status of drug resistance among gram negative bacilli isolated from admitted cases in a tertiary care centre. J Assoc Physicians India 2003;51:28-31.
16. Wiener J, Quinn JP, Bradford PA, Goering RV, Nathan C, Bush K, et al. Multiple antibiotic resistant Klebsiella and Escherichia coli in a nursing home. JAMA 1999;281:517-23.
17. Gupta K, Scholes D, Stamm WE. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA 1999;281:736-8.
18. Suman E, Bhat GK. Urinary tract infection in children due to drug resistant bacteria: A study from South India. J Trop Pediatr 2001;47:374-5.
19. Anathakrishan AN, Kanungo R, Kumar A, Badrinath S. Detection of extended spectrum β-lactamase producers among surgical wound infections and burn patients in JIPMER. Indian J Med Microbiol 2000;18:160-5.
20. Shukla I, Tiwari R, Agarwal M. Prevalence of extended spectrum β-lactamase in a tertiary care hospital. Indian J Med Microbiol 2004;22:87-91.
21. Johnson JR, Kushowski MA, Owens K, Gajewski A, Winokur PL. Phylogenetic origin and virulence genotype in relation to resistance to fluoroquinolones and/or extended spectrum cephalosporins and cephamycins among Escherichia coli isolates form animals and humans. J Infect Dis 2003;188:759-68.
22. Rice LB. Successful interventions for gram negative resistance for extended spectrum beta-lactam antibiotics. Pharmacotherapy 1999;19:120S-8S.